0001752724-21-001932.txt : 20210113
0001752724-21-001932.hdr.sgml : 20210113
20210113161536
ACCESSION NUMBER: 0001752724-21-001932
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201031
FILED AS OF DATE: 20210113
DATE AS OF CHANGE: 20210113
EFFECTIVENESS DATE: 20210113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALGER GLOBAL FOCUS FUND
CENTRAL INDEX KEY: 0001219064
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1031
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-21308
FILM NUMBER: 21526240
BUSINESS ADDRESS:
STREET 1: 360 PARK AVENUE SOUTH
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 212-806-8833
MAIL ADDRESS:
STREET 1: 360 PARK AVENUE SOUTH
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: ALGER GLOBAL GROWTH FUND
DATE OF NAME CHANGE: 20130610
FORMER COMPANY:
FORMER CONFORMED NAME: ALGER CHINA-US GROWTH FUND
DATE OF NAME CHANGE: 20080924
FORMER COMPANY:
FORMER CONFORMED NAME: CHINA US GROWTH FUND
DATE OF NAME CHANGE: 20040121
0001219064
S000009192
ALGER GLOBAL FOCUS FUND
C000024981
ALGER GLOBAL FOCUS FUND CLASS A
CHUSX
C000060632
ALGER GLOBAL FOCUS FUND CLASS C
CHUCX
C000127110
ALGER GLOBAL FOCUS FUND CLASS I
AFGIX
C000127111
ALGER GLOBAL FOCUS FUND CLASS Z
AFGZX
N-CEN
1
primary_doc.xml
X0303
N-CEN
LIVE
0001219064
XXXXXXXX
811-21308
true
false
false
N-1A
true
Alger Global Focus Fund
811-21308
0001219064
5493000R8VYGCU6Y1832
360 Park Avenue South
NEW YORK
10010-1714
US-NY
US
800-992-3863
BROWN BROTHERS HARRIMAN & CO.
50 Post Office Square
BOSTON
02110-1543
617-772-1818
Books and records
N
N
N-1A
1
Y
Hilary M. Alger
001164468
Y
Roger P. Cheever
N/A
N
Stephen E. O'Neil
N/A
N
Nathan E. Saint-Amand M.D.
N/A
N
Charles F. Baird
004827821
N
David Rosenberg
N/A
N
Tina Payne
N/A
360 Park Avenue South
New York
10010-1714
XXXXXX
N
N
N
N
N
N
FRED ALGER & COMPANY, LLC
008-15900
000005300
549300TITGLG7BXCGB39
Y
N
Deloitte & Touche LLP
34
549300FJV7IV1ZHGAV28
N
N
N
N
N
N
N
Alger Global Focus Fund
S000009192
5493000R8VYGCU6Y1832
N
4
0
0
N/A
N
N
Y
N
N/A
N/A
N/A
N/A
Y
Y
N
N
Fred Alger Management, LLC
801-6709
000106750
549300TITGLG7BXCGB39
N
UMB Fund Services, Inc.
084-05792
N/A
N
N
N
Refinitiv US LLC
213800HQORQAP68CJJ04
N
N
Brown Brothers Harriman & Co.
5493006KMX1VFTPYPW14
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
FRED ALGER MANAGEMENT, LLC
549300TITGLG7BXCGB39
Y
N
UMB Fund Services, Inc
084-05792
SEC file number
N
Y
N
FRED ALGER MANAGEMENT, LLC
549300TITGLG7BXCGB39
Y
N
Brown Brothers Harriman & Co.
5493006KMX1VFTPYPW14
N
Y
N
Fred Alger & Company, LLC
008-15900
000005300
549300TITGLG7BXCGB39
373.88
MORGAN STANLEY & CO. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
1667.48000000
J.P. MORGAN SECURITIES LLC
008-35008
000000079
ZBUT11V806EZRVTWT807
3865.55000000
UBS Securities LLC
008-22651
000007654
T6FIZBDPKLYJKFCRVK44
3179.59000000
EXANE, INC.
008-49569
000041784
6SDWK6FV8H98XAGSYS75
6039.93000000
Goldman Sachs & Co, LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
10016.70000000
BNY MELLON CAPITAL MARKETS, LLC
008-35255
000017454
VJW2DOOHGDT6PR0ZRO63
2252.60000000
Citic Securities
N/A
N/A
213800YMG8YN4O5CX140
HK
11646.68000000
CREDIT SUISSE SECURITIES (USA) LLC
008-00422
000000816
1V8Y6QCX6YMJ2OELII46
3141.76000000
MERRILL LYNCH, PIERCE, FENNER & SMITH INC.
008-07221
000007691
8NAV47T0Y26Q87Y0QP81
3538.49000000
Jefferies LLC
008-15074
000002347
58PU97L1C0WSRCWADL48
2071.38000000
55979.41000000
BERENBERG BANK Stiftung von 1990
N/A
N/A
5299000WI2BXRB3KKL92
DE
210347.71000000
MORGAN STANLEY & CO. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
32076.00000000
J.P. MORGAN SECURITIES LLC
008-35008
000000079
ZBUT11V806EZRVTWT807
180162.22000000
MERRILL LYNCH, PIERCE, FENNER & SMITH INC.
008-07221
000007691
8NAV47T0Y26Q87Y0QP81
298106.28000000
720692.21000000
N
20938651.51000000
N
N
N
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
Alger_Global_Focus_Fund.txt
AUDITOR'S LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the shareholders and the Board of Trustees of Alger Global Focus Fund:
In planning and performing our audit of the financial statements of Alger
Global Focus Fund (the "Trust") as of and for the year ended October 31, 2020,
in accordance with the standards of the Public Company Accounting Oversight
Board (United States) (PCAOB), we considered the Trust's internal control over
financial reporting, including controls over safeguarding securities, as a
basis for designing our auditing procedures for the purpose of expressing our
opinion on the financial statements and to comply with the requirements of
Form N-CEN, but not for the purpose of expressing an opinion on the
effectiveness of the Trust's internal control over financial reporting.
Accordingly, we express no such opinion.
The management of the Trust is responsible for establishing and maintaining
effective internal control over financial reporting. In fulfilling this
responsibility, estimates and judgments by management are required to assess
the expected benefits and related costs of controls. A trust's internal
control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles. A trust's internal control over financial
reporting includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the trust; (2)
provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the
trust are being made only in accordance with authorizations of management and
directors of the trust; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use, or
disposition of a trust's assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions or that the degree of
compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the
design or operation of a control does not allow management or employees, in
the normal course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of
the trust's annual or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Trust's internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be
material weaknesses under standards established by the PCAOB. However, we
noted no deficiencies in the Trust's internal control over financial reporting
and its operation, including controls for safeguarding securities, that we
consider to be a material weakness, as defined above, as of October 31, 2020.
This report is intended solely for the information and use of management and
the Board of Trustees of the Trust and the Securities and Exchange Commission
and is not intended to be and should not be used by anyone other than these
specified parties.
Deloitte & Touche LLP
New York, New York
December 21, 2020